When.com Web Search

  1. Ads

    related to: switching from anastrozole to tamoxifen

Search results

  1. Results From The WOW.Com Content Network
  2. Estrogen deprivation therapy - Wikipedia

    en.wikipedia.org/wiki/Estrogen_deprivation_therapy

    Estrogen deprivation therapy, also known as endocrine therapy, is a form of hormone therapy that is used in the treatment of breast cancer.Modalities include antiestrogens or estrogen blockers such as selective estrogen receptor modulators (SERMs) like tamoxifen, selective estrogen receptor degraders like fulvestrant, and aromatase inhibitors like anastrozole and ovariectomy.

  3. Antiestrogen withdrawal response - Wikipedia

    en.wikipedia.org/wiki/Antiestrogen_withdrawal...

    The antiestrogen withdrawal response is a paradoxical improvement in breast cancer caused by discontinuation of antiestrogen therapy for breast cancer. [1] [2] [3] [4 ...

  4. Antiestrogen - Wikipedia

    en.wikipedia.org/wiki/Antiestrogen

    Antiestrogens include selective estrogen receptor modulators (SERMs) like tamoxifen, clomifene, and raloxifene, the ER silent antagonist and selective estrogen receptor degrader (SERD) fulvestrant, [6] [7] aromatase inhibitors (AIs) like anastrozole, and antigonadotropins including androgens/anabolic steroids, progestogens, and GnRH analogues.

  5. What is Anastrozole? The breast cancer drug that can cut risk ...

    www.aol.com/news/anastrozole-breast-cancer-drug...

    Scientists have found that the hormone therapy - called anastrozole - can p revent women from developing breast cancer and that the protective effect lasts for years after the treatment has ended.

  6. AstraZeneca Launches New Digital Resources for ARIMIDEX ... - AOL

    www.aol.com/2012/11/12/astrazeneca-launches-new...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Anastrozole - Wikipedia

    en.wikipedia.org/wiki/Anastrozole

    Anastrozole is used in the treatment and prevention of breast cancer in women. [7] The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was of localized breast cancer and women received either anastrozole, the selective estrogen receptor modulator tamoxifen, or both for five years, followed by five years of follow-up. [13]